Veeva Systems Key Executives
This section highlights Veeva Systems's key executives, including their titles and compensation details.
Find Contacts at Veeva Systems
(Showing 0 of )
Veeva Systems Earnings
This section highlights Veeva Systems's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Last Earnings Results
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q4 | 2025 | 2025-03-05 | $1.60 | $1.74 |
| Read Transcript | Q3 | 2025 | 2024-12-05 | $1.58 | $1.75 |
| Read Transcript | Q2 | 2025 | 2024-08-28 | $1.53 | $1.62 |
| Read Transcript | Q1 | 2025 | 2024-05-30 | $1.42 | $1.50 |
| Read Transcript | Q4 | 2024 | 2024-02-29 | $1.30 | $1.38 |
| Read Transcript | Q3 | 2024 | 2023-12-06 | $1.28 | $1.34 |
| Read Transcript | Q2 | 2024 | 2023-08-30 | $1.12 | $1.21 |
| Read Transcript | Q1 | 2024 | 2023-05-31 | $0.79 | $0.91 |
| Read Transcript | Q4 | 2023 | 2023-03-02 | N/A | N/A |
| Read Transcript | Q3 | 2023 | 2022-12-01 | $1.07 | $1.13 |
| Read Transcript | Q2 | 2023 | 2022-08-31 | $1.01 | $1.03 |
| Read Transcript | Q1 | 2023 | 2022-06-01 | $0.92 | $0.99 |
Financial Statements
Access annual & quarterly financial statements for Veeva Systems, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | January 31, 2025 | January 31, 2024 | January 31, 2023 | January 31, 2022 | January 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.75B | $2.36B | $2.16B | $1.85B | $1.47B |
| Cost of Revenue | $699.64M | $677.29M | $609.40M | $503.68M | $408.93M |
| Gross Profit | $2.05B | $1.69B | $1.55B | $1.35B | $1.06B |
| Gross Profit Ratio | 74.53% | 71.35% | 71.72% | 72.79% | 72.09% |
| Research and Development Expenses | $693.08M | $629.03M | $520.28M | $382.04M | $294.22M |
| General and Administrative Expenses | $265.74M | $246.54M | $217.59M | $171.51M | $149.11M |
| Selling and Marketing Expenses | $396.73M | $381.47M | $348.69M | $288.06M | $235.01M |
| Selling General and Administrative Expenses | $662.47M | $628.02M | $566.29M | $459.57M | $384.13M |
| Other Expenses | $- | $- | $50.01M | $6.82M | $16.20M |
| Operating Expenses | $1.36B | $1.26B | $1.09B | $841.60M | $678.35M |
| Cost and Expenses | $2.06B | $1.93B | $1.70B | $1.35B | $1.09B |
| Interest Income | $207.99M | $133.75M | $45.86M | $14.73M | $15.86M |
| Interest Expense | $- | $- | $- | $14.73M | $- |
| Depreciation and Amortization | $- | $32.63M | $37.66M | $36.97M | $39.35M |
| EBITDA | $691.43M | $461.96M | $488.21M | $505.50M | $407.25M |
| EBITDA Ratio | 25.17% | 19.54% | 22.65% | 27.31% | 27.80% |
| Operating Income | $691.43M | $429.33M | $459.09M | $505.50M | $377.79M |
| Operating Income Ratio | 25.17% | 18.16% | 21.30% | 27.31% | 25.79% |
| Total Other Income Expenses Net | $227.95M | $158.69M | $50.01M | $6.82M | $16.20M |
| Income Before Tax | $919.38M | $588.02M | $509.10M | $512.31M | $393.99M |
| Income Before Tax Ratio | 33.47% | 24.88% | 23.62% | 27.68% | 26.89% |
| Income Tax Expense | $205.24M | $62.32M | $21.39M | $84.92M | $13.99M |
| Net Income | $714.14M | $525.71M | $487.71M | $427.39M | $380.00M |
| Net Income Ratio | 26.00% | 22.24% | 22.63% | 23.09% | 25.94% |
| EPS | $4.41 | $3.27 | $3.14 | $2.79 | $2.52 |
| EPS Diluted | $4.32 | $3.22 | $3.00 | $2.63 | $2.36 |
| Weighted Average Shares Outstanding | 161.88M | 160.53M | 155.38M | 153.25M | 150.67M |
| Weighted Average Shares Outstanding Diluted | 165.23M | 163.49M | 162.44M | 162.28M | 160.73M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 | October 31, 2021 | July 31, 2021 | April 30, 2021 | January 31, 2021 | October 31, 2020 | July 31, 2020 | April 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $720.89M | $699.21M | $676.18M | $650.35M | $630.62M | $616.50M | $590.23M | $526.33M | $563.39M | $552.35M | $534.22M | $505.10M | $485.50M | $476.11M | $455.59M | $433.57M | $396.76M | $377.52M | $353.68M | $337.11M |
| Cost of Revenue | $180.99M | $174.39M | $170.37M | $173.88M | $177.56M | $167.68M | $169.02M | $166.66M | $164.31M | $153.91M | $151.67M | $139.51M | $135.88M | $129.56M | $122.10M | $116.14M | $113.85M | $103.00M | $97.20M | $94.88M |
| Gross Profit | $539.89M | $524.82M | $505.81M | $476.46M | $453.05M | $448.82M | $421.21M | $359.66M | $399.07M | $398.44M | $382.55M | $365.59M | $349.62M | $346.55M | $333.50M | $317.44M | $282.91M | $274.52M | $256.48M | $242.23M |
| Gross Profit Ratio | 74.89% | 75.06% | 74.80% | 73.26% | 71.84% | 72.80% | 71.36% | 68.33% | 70.83% | 72.14% | 71.61% | 72.38% | 72.01% | 72.79% | 73.20% | 73.21% | 71.31% | 72.72% | 72.52% | 71.85% |
| Research and Development Expenses | $181.53M | $172.41M | $176.43M | $162.71M | $163.54M | $161.28M | $157.23M | $146.96M | $142.54M | $130.26M | $134.01M | $113.47M | $105.28M | $98.64M | $94.90M | $83.23M | $81.94M | $79.99M | $70.05M | $62.24M |
| General and Administrative Expenses | $70.74M | $72.36M | $61.37M | $61.28M | $58.66M | $62.28M | $86.42M | $82.80M | $58.56M | $52.87M | $57.83M | $48.33M | $45.39M | $42.78M | $42.19M | $41.16M | $40.03M | $35.24M | $37.17M | $36.67M |
| Selling and Marketing Expenses | $99.20M | $98.69M | $101.53M | $97.30M | $99.20M | $96.77M | $73.51M | $68.37M | $89.05M | $93.91M | $89.62M | $76.11M | $79.24M | $72.42M | $71.79M | $64.61M | $62.10M | $57.98M | $59.17M | $55.76M |
| Selling General and Administrative Expenses | $169.94M | $171.05M | $162.89M | $158.58M | $154.25M | $159.06M | $159.93M | $151.17M | $147.61M | $146.78M | $147.45M | $124.44M | $124.62M | $115.20M | $113.97M | $105.77M | $102.13M | $93.22M | $96.34M | $92.42M |
| Other Expenses | $- | $- | $- | $51.73M | $-111.26M | $42.19M | $38.83M | $30.25M | $26.44M | $12.46M | $8.40M | $2.71M | $-239.00K | $824.00K | $1.67M | $4.56M | $6.45M | $3.46M | $2.88M | $3.41M |
| Operating Expenses | $351.47M | $343.46M | $339.32M | $321.29M | $317.79M | $320.33M | $317.16M | $298.13M | $290.15M | $277.04M | $281.46M | $237.91M | $229.90M | $213.84M | $208.87M | $188.99M | $184.07M | $173.22M | $166.40M | $154.66M |
| Cost and Expenses | $532.46M | $517.85M | $509.69M | $495.17M | $495.35M | $488.02M | $486.18M | $464.80M | $454.47M | $430.95M | $433.13M | $377.43M | $365.78M | $343.40M | $330.97M | $305.13M | $297.92M | $276.21M | $263.60M | $249.54M |
| Interest Income | $- | $- | $- | $- | $- | $- | $31.45M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Interest Expense | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $239.00K | $- | $- | $- | $- | $- | $- | $- |
| Depreciation and Amortization | $- | $- | $11.02M | $8.50M | $9.71M | $8.36M | $8.09M | $8.81M | $9.04M | $9.09M | $10.02M | $9.95M | $9.71M | $9.86M | $9.87M | $8.83M | $6.74M | $7.53M | $7.32M | $7.88M |
| EBITDA | $188.42M | $181.35M | $177.51M | $163.67M | $144.97M | $136.85M | $112.14M | $69.08M | $116.60M | $128.56M | $108.32M | $134.73M | $126.76M | $139.61M | $124.62M | $135.07M | $105.58M | $108.83M | $97.40M | $95.44M |
| EBITDA Ratio | 26.14% | 25.94% | 26.25% | 25.17% | 22.99% | 22.20% | 19.00% | 13.12% | 20.70% | 23.28% | 20.28% | 26.67% | 26.11% | 29.32% | 27.35% | 31.15% | 26.61% | 28.83% | 27.54% | 28.31% |
| Operating Income | $188.42M | $181.35M | $166.49M | $155.17M | $135.26M | $128.49M | $104.05M | $61.53M | $108.92M | $121.40M | $101.09M | $127.67M | $119.72M | $132.71M | $124.62M | $128.45M | $98.84M | $101.31M | $90.08M | $87.56M |
| Operating Income Ratio | 26.14% | 25.94% | 24.62% | 23.86% | 21.45% | 20.84% | 17.63% | 11.69% | 19.33% | 21.98% | 18.92% | 25.28% | 24.66% | 27.87% | 27.35% | 29.62% | 24.91% | 26.83% | 25.47% | 25.98% |
| Total Other Income Expenses Net | $56.71M | $60.94M | $58.57M | $51.73M | $47.43M | $42.19M | $38.83M | $30.25M | $26.44M | $12.46M | $8.40M | $2.71M | $-239.00K | $824.00K | $1.67M | $4.56M | $6.45M | $3.46M | $2.88M | $3.41M |
| Income Before Tax | $245.13M | $242.29M | $225.06M | $206.90M | $182.69M | $170.68M | $142.88M | $91.78M | $135.36M | $133.86M | $109.49M | $130.38M | $119.48M | $133.53M | $126.29M | $133.01M | $105.29M | $104.76M | $92.96M | $90.98M |
| Income Before Tax Ratio | 34.00% | 34.65% | 33.28% | 31.81% | 28.97% | 27.68% | 24.21% | 17.44% | 24.03% | 24.23% | 20.50% | 25.81% | 24.61% | 28.05% | 27.72% | 30.68% | 26.54% | 27.75% | 26.28% | 26.99% |
| Income Tax Expense | $49.51M | $56.48M | $54.02M | $45.24M | $35.30M | $35.52M | $31.25M | $-39.74M | $-53.17M | $25.41M | $18.89M | $30.27M | $22.38M | $27.66M | $17.43M | $17.44M | $2.37M | $7.80M | $-589.00K | $4.41M |
| Net Income | $195.62M | $185.81M | $171.04M | $161.66M | $147.40M | $135.16M | $111.63M | $131.52M | $188.53M | $108.46M | $90.60M | $100.11M | $97.10M | $105.87M | $108.86M | $115.57M | $102.92M | $96.96M | $93.55M | $86.57M |
| Net Income Ratio | 27.14% | 26.57% | 25.30% | 24.86% | 23.37% | 21.92% | 18.91% | 24.99% | 33.46% | 19.64% | 16.96% | 19.82% | 20.00% | 22.24% | 23.89% | 26.65% | 25.94% | 25.68% | 26.45% | 25.68% |
| EPS | $1.20 | $1.15 | $1.06 | $1.00 | $0.92 | $0.84 | $0.70 | $0.82 | $1.20 | $0.70 | $0.58 | $0.65 | $0.63 | $0.69 | $0.71 | $0.76 | $0.68 | $0.64 | $0.62 | $0.58 |
| EPS Diluted | $1.18 | $1.13 | $1.04 | $0.98 | $0.90 | $0.83 | $0.68 | $0.81 | $1.16 | $0.67 | $0.56 | $0.62 | $0.60 | $0.65 | $0.67 | $0.71 | $0.64 | $0.60 | $0.58 | $0.54 |
| Weighted Average Shares Outstanding | 162.39M | 161.99M | 161.71M | 161.42M | 161.09M | 160.77M | 160.40M | 159.85M | 156.51M | 155.39M | 154.95M | 154.51M | 153.94M | 153.51M | 153.09M | 152.44M | 151.69M | 150.99M | 150.41M | 149.54M |
| Weighted Average Shares Outstanding Diluted | 165.67M | 164.98M | 164.56M | 164.39M | 164.07M | 163.76M | 163.28M | 162.52M | 162.10M | 162.29M | 162.13M | 161.93M | 162.68M | 163.03M | 162.76M | 162.21M | 162.01M | 161.71M | 186.41M | 159.47M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | January 31, 2025 | January 31, 2024 | January 31, 2023 | January 31, 2022 | January 31, 2021 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.12B | $703.49M | $886.47M | $1.14B | $730.50M |
| Short Term Investments | $4.03B | $3.32B | $2.22B | $1.24B | $933.12M |
| Cash and Short Term Investments | $5.15B | $4.03B | $3.10B | $2.38B | $1.66B |
| Net Receivables | $1.06B | $888.54M | $785.23M | $694.40M | $611.59M |
| Inventory | $- | $- | $1 | $1 | $- |
| Other Current Assets | $101.46M | $86.92M | $81.46M | $73.36M | $70.77M |
| Total Current Assets | $6.31B | $5.00B | $3.97B | $3.11B | $2.31B |
| Property Plant Equipment Net | $119.78M | $104.13M | $105.15M | $104.14M | $110.57M |
| Goodwill | $439.88M | $439.88M | $439.88M | $439.88M | $436.03M |
| Intangible Assets | $44.46M | $63.02M | $82.48M | $101.94M | $114.59M |
| Goodwill and Intangible Assets | $484.34M | $502.89M | $522.35M | $541.82M | $550.62M |
| Long Term Investments | $- | $- | $3.19M | $3.19M | $42.07M |
| Tax Assets | $343.92M | $233.46M | $136.70M | $5.10M | $14.10M |
| Other Non-Current Assets | $82.92M | $67.22M | $67.59M | $55.05M | $17.88M |
| Total Non-Current Assets | $1.03B | $907.71M | $834.98M | $709.28M | $735.24M |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $7.34B | $5.91B | $4.80B | $3.82B | $3.05B |
| Account Payables | $30.45M | $31.51M | $41.68M | $20.35M | $23.25M |
| Short Term Debt | $9.97M | $29.80M | $22.61M | $21.96M | $23.45M |
| Tax Payables | $9.02M | $19.49M | $4.95M | $7.76M | $2.59M |
| Deferred Revenue | $1.27B | $1.05B | $869.28M | $731.75M | $616.99M |
| Other Current Liabilities | $74.99M | $68.78M | $68.28M | $58.96M | $49.67M |
| Total Current Liabilities | $1.40B | $1.18B | $1.01B | $840.78M | $715.95M |
| Long Term Debt | $65.81M | $46.44M | $49.67M | $43.61M | $51.39M |
| Deferred Revenue Non-Current | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $587.00K | $2.05M | $1.49M | $2.22M | $1.83M |
| Other Non-Current Liabilities | $42.59M | $38.72M | $30.08M | $18.23M | $10.57M |
| Total Non-Current Liabilities | $108.98M | $87.21M | $81.24M | $64.05M | $63.80M |
| Other Liabilities | $- | $- | $- | $- | $- |
| Total Liabilities | $1.51B | $1.27B | $1.09B | $904.83M | $779.75M |
| Preferred Stock | $- | $- | $- | $- | $- |
| Common Stock | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K |
| Retained Earnings | $3.45B | $2.74B | $2.21B | $1.73B | $1.30B |
| Accumulated Other Comprehensive Income Loss | $-8.42M | $-10.64M | $-31.13M | $-11.96M | $992.00K |
| Other Total Stockholders Equity | $2.39B | $1.92B | $1.53B | $1.20B | $965.67M |
| Total Stockholders Equity | $5.83B | $4.64B | $3.72B | $2.91B | $2.27B |
| Total Equity | $5.83B | $4.64B | $3.72B | $2.91B | $2.27B |
| Total Liabilities and Stockholders Equity | $7.34B | $5.91B | $4.80B | $3.82B | $3.05B |
| Minority Interest | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $7.34B | $5.91B | $4.80B | $3.82B | $3.05B |
| Total Investments | $4.03B | $3.32B | $2.22B | $1.24B | $933.12M |
| Total Debt | $75.78M | $55.77M | $60.98M | $54.59M | $63.12M |
| Net Debt | $-1.04B | $-647.71M | $-825.49M | $-1.08B | $-667.39M |
Balance Sheet Charts
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 | October 31, 2021 | July 31, 2021 | April 30, 2021 | January 31, 2021 | October 31, 2020 | July 31, 2020 | April 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $1.12B | $1.04B | $1.17B | $1.20B | $703.49M | $743.71M | $742.61M | $1.09B | $886.47M | $865.16M | $1.14B | $1.24B | $1.14B | $1.15B | $1.06B | $1.18B | $730.50M | $634.26M | $795.78M | $720.78M |
| Short Term Investments | $4.03B | $4.02B | $3.72B | $3.57B | $3.32B | $3.20B | $3.13B | $2.52B | $2.22B | $2.16B | $1.78B | $1.60B | $1.24B | $1.20B | $1.20B | $965.45M | $933.12M | $956.17M | $699.71M | $660.20M |
| Cash and Short Term Investments | $5.15B | $5.06B | $4.89B | $4.77B | $4.03B | $3.94B | $3.87B | $3.61B | $3.10B | $3.02B | $2.92B | $2.84B | $2.38B | $2.35B | $2.26B | $2.15B | $1.66B | $1.59B | $1.50B | $1.38B |
| Net Receivables | $1.06B | $301.29M | $404.15M | $401.09M | $888.54M | $300.34M | $416.61M | $451.01M | $785.23M | $324.94M | $391.00M | $391.65M | $694.40M | $279.02M | $334.72M | $313.69M | $611.59M | $236.67M | $257.45M | $273.19M |
| Inventory | $- | $- | $- | $- | $- | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $1 | $- | $1 | $1 | $- | $1 | $1 | $- |
| Other Current Assets | $101.46M | $82.89M | $78.61M | $78.82M | $86.92M | $93.14M | $76.41M | $122.22M | $81.46M | $77.94M | $92.04M | $88.38M | $73.36M | $58.51M | $67.11M | $61.87M | $70.77M | $51.70M | $64.86M | $42.20M |
| Total Current Assets | $6.31B | $5.45B | $5.37B | $5.24B | $5.00B | $4.34B | $4.36B | $4.19B | $3.97B | $3.39B | $3.36B | $3.28B | $3.11B | $2.66B | $2.63B | $2.50B | $2.31B | $1.85B | $1.79B | $1.68B |
| Property Plant Equipment Net | $119.78M | $116.02M | $99.83M | $102.62M | $104.13M | $105.74M | $108.00M | $102.24M | $105.15M | $108.38M | $110.95M | $102.70M | $104.14M | $103.96M | $105.69M | $106.02M | $110.57M | $107.18M | $103.86M | $99.81M |
| Goodwill | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $439.88M | $437.26M | $437.26M | $436.03M | $436.03M | $436.03M | $438.53M | $438.53M |
| Intangible Assets | $44.46M | $48.53M | $53.34M | $58.23M | $63.02M | $67.92M | $72.83M | $77.73M | $82.48M | $87.38M | $92.29M | $97.19M | $101.94M | $102.56M | $107.25M | $110.17M | $114.59M | $119.17M | $124.42M | $129.40M |
| Goodwill and Intangible Assets | $484.34M | $488.40M | $493.22M | $498.11M | $502.89M | $507.80M | $512.70M | $517.61M | $522.35M | $527.26M | $532.16M | $537.07M | $541.82M | $539.82M | $544.51M | $546.20M | $550.62M | $555.19M | $562.95M | $567.93M |
| Long Term Investments | $- | $- | $- | $3.18M | $3.18M | $19.73M | $22.46M | $3.19M | $3.19M | $-710.83M | $-433.07M | $3.19M | $33.11M | $34.09M | $37.34M | $40.01M | $42.07M | $35.47M | $34.65M | $34.18M |
| Tax Assets | $343.92M | $322.65M | $291.04M | $266.06M | $233.46M | $218.35M | $184.33M | $156.38M | $136.70M | $98.57M | $62.06M | $40.67M | $5.10M | $4.88M | $7.59M | $13.85M | $14.10M | $15.69M | $12.17M | $11.70M |
| Other Non-Current Assets | $82.92M | $78.62M | $78.90M | $72.63M | $64.03M | $38.40M | $38.90M | $55.83M | $67.59M | $772.85M | $488.34M | $52.29M | $25.13M | $24.93M | $24.46M | $21.01M | $17.88M | $17.11M | $17.35M | $15.73M |
| Total Non-Current Assets | $1.03B | $1.01B | $962.99M | $942.61M | $907.71M | $890.01M | $866.39M | $835.24M | $834.98M | $796.23M | $760.44M | $735.93M | $709.28M | $707.69M | $719.59M | $727.08M | $735.24M | $730.64M | $730.98M | $729.35M |
| Other Assets | $- | $- | $- | $1 | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $7.34B | $6.45B | $6.33B | $6.19B | $5.91B | $5.23B | $5.23B | $5.02B | $4.80B | $4.18B | $4.12B | $4.01B | $3.82B | $3.37B | $3.35B | $3.22B | $3.05B | $2.58B | $2.52B | $2.40B |
| Account Payables | $30.45M | $31.84M | $28.31M | $31.93M | $31.51M | $36.24M | $49.93M | $44.40M | $41.68M | $40.93M | $30.91M | $25.40M | $20.35M | $25.61M | $21.30M | $18.86M | $23.25M | $21.32M | $16.48M | $15.04M |
| Short Term Debt | $9.97M | $9.16M | $20.36M | $20.78M | $18.67M | $19.28M | $21.30M | $21.47M | $11.31M | $23.33M | $22.73M | $23.21M | $21.96M | $21.61M | $22.21M | $22.56M | $23.45M | $22.10M | $22.24M | $20.25M |
| Tax Payables | $9.02M | $10.80M | $11.93M | $77.45M | $19.49M | $6.56M | $24.14M | $4.62M | $4.95M | $54.47M | $5.14M | $50.98M | $7.76M | $14.48M | $2.57M | $6.30M | $2.59M | $2.56M | $2.46M | $4.44M |
| Deferred Revenue | $1.27B | $739.66M | $956.38M | $1.03B | $1.05B | $644.46M | $836.50M | $869.92M | $869.28M | $510.10M | $684.64M | $723.72M | $731.75M | $417.75M | $558.72M | $608.67M | $616.99M | $331.17M | $421.17M | $470.26M |
| Other Current Liabilities | $74.99M | $65.54M | $53.46M | $63.67M | $59.45M | $61.71M | $70.08M | $65.89M | $79.59M | $61.46M | $55.96M | $55.54M | $58.96M | $57.44M | $58.03M | $53.16M | $49.67M | $40.25M | $39.14M | $40.34M |
| Total Current Liabilities | $1.40B | $857.00M | $1.07B | $1.22B | $1.18B | $768.25M | $1.00B | $1.01B | $1.01B | $690.28M | $799.39M | $878.86M | $840.78M | $536.89M | $662.84M | $709.55M | $715.95M | $417.39M | $501.48M | $550.34M |
| Long Term Debt | $65.81M | $62.55M | $43.91M | $45.35M | $46.44M | $48.03M | $47.85M | $47.49M | $49.67M | $50.23M | $52.11M | $42.46M | $43.61M | $45.24M | $47.63M | $48.67M | $51.39M | $47.97M | $46.19M | $42.43M |
| Deferred Revenue Non-Current | $- | $- | $- | $-1 | $-1 | $- | $- | $- | $- | $- | $- | $- | $- | $1.94M | $- | $- | $- | $- | $- | $- |
| Deferred Tax Liabilities Non-Current | $587.00K | $475.00K | $591.00K | $705.00K | $2.05M | $1.15M | $1.28M | $1.41M | $1.49M | $1.55M | $1.66M | $1.73M | $2.22M | $1.94M | $7.51M | $6.49M | $1.83M | $1.00M | $1.82M | $1.67M |
| Other Non-Current Liabilities | $42.59M | $31.43M | $31.20M | $28.84M | $38.72M | $28.58M | $24.41M | $25.10M | $30.08M | $21.87M | $19.50M | $19.90M | $18.23M | $14.06M | $13.31M | $12.46M | $10.57M | $10.90M | $10.19M | $9.14M |
| Total Non-Current Liabilities | $108.98M | $94.45M | $75.70M | $74.89M | $87.21M | $77.75M | $73.55M | $74.00M | $81.24M | $73.64M | $73.26M | $64.09M | $64.05M | $61.24M | $68.45M | $67.62M | $63.80M | $59.87M | $58.20M | $53.24M |
| Other Liabilities | $- | $- | $- | $1 | $1 | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $1.51B | $951.45M | $1.15B | $1.30B | $1.27B | $846.00M | $1.08B | $1.08B | $1.09B | $763.92M | $872.65M | $942.95M | $904.83M | $598.12M | $731.29M | $777.16M | $779.75M | $477.26M | $559.68M | $603.58M |
| Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K | $2.00K |
| Retained Earnings | $3.45B | $3.26B | $3.07B | $2.90B | $2.74B | $2.59B | $2.46B | $2.35B | $2.21B | $2.03B | $1.92B | $1.83B | $1.73B | $1.63B | $1.52B | $1.42B | $1.30B | $1.20B | $1.10B | $1.01B |
| Accumulated Other Comprehensive Income Loss | $-8.42M | $-6.46M | $-5.58M | $-30.65M | $-10.64M | $-37.54M | $-34.38M | $-25.76M | $-31.13M | $-45.64M | $-27.34M | $-24.21M | $-11.96M | $-5.74M | $-2.69M | $-2.30M | $992.00K | $3.50M | $6.17M | $2.15M |
| Other Total Stockholders Equity | $2.39B | $2.25B | $2.12B | $2.02B | $1.92B | $1.82B | $1.73B | $1.62B | $1.53B | $1.44B | $1.35B | $1.27B | $1.20B | $1.15B | $1.10B | $1.03B | $965.67M | $906.14M | $850.78M | $792.66M |
| Total Stockholders Equity | $5.83B | $5.50B | $5.18B | $4.89B | $4.64B | $4.38B | $4.15B | $3.94B | $3.72B | $3.42B | $3.24B | $3.07B | $2.91B | $2.77B | $2.62B | $2.44B | $2.27B | $2.11B | $1.96B | $1.80B |
| Total Equity | $5.83B | $5.50B | $5.18B | $4.89B | $4.64B | $4.38B | $4.15B | $3.94B | $3.72B | $3.42B | $3.24B | $3.07B | $2.91B | $2.77B | $2.62B | $2.44B | $2.27B | $2.11B | $1.96B | $1.80B |
| Total Liabilities and Stockholders Equity | $7.34B | $6.45B | $6.33B | $6.19B | $5.91B | $5.23B | $5.23B | $5.02B | $4.80B | $4.18B | $4.12B | $4.01B | $3.82B | $3.37B | $3.35B | $3.22B | $3.05B | $2.58B | $2.52B | $2.40B |
| Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities and Total Equity | $7.34B | $6.45B | $6.33B | $6.19B | $5.91B | $5.23B | $5.23B | $5.02B | $4.80B | $4.18B | $4.12B | $4.01B | $3.82B | $3.37B | $3.35B | $3.22B | $3.05B | $2.58B | $2.52B | $2.40B |
| Total Investments | $4.03B | $4.02B | $3.72B | $3.57B | $3.33B | $3.20B | $3.13B | $2.52B | $2.22B | $2.16B | $1.78B | $1.60B | $1.24B | $1.20B | $1.20B | $965.45M | $933.12M | $956.17M | $699.71M | $660.20M |
| Total Debt | $75.78M | $71.70M | $54.09M | $55.74M | $55.77M | $57.67M | $58.51M | $58.23M | $60.98M | $61.89M | $63.47M | $54.07M | $54.59M | $56.04M | $58.73M | $59.95M | $63.12M | $59.02M | $57.30M | $52.56M |
| Net Debt | $-1.04B | $-972.81M | $-1.11B | $-1.14B | $-647.71M | $-686.05M | $-684.10M | $-1.04B | $-825.49M | $-803.27M | $-1.08B | $-1.19B | $-1.08B | $-1.09B | $-1.01B | $-1.13B | $-667.39M | $-575.25M | $-738.48M | $-668.22M |
Annual Cash Flow
| Breakdown | January 31, 2025 | January 31, 2024 | January 31, 2023 | January 31, 2022 | January 31, 2021 |
|---|---|---|---|---|---|
| Net Income | $714.14M | $525.71M | $487.71M | $427.39M | $380.00M |
| Depreciation and Amortization | $39.38M | $32.63M | $29.12M | $27.45M | $29.45M |
| Deferred Income Tax | $-112.27M | $-105.37M | $-127.50M | $11.08M | $-1.05M |
| Stock Based Compensation | $437.35M | $393.73M | $351.91M | $234.64M | $185.00M |
| Change in Working Capital | $7.62M | $60.82M | $-151.75M | $-97.76M | $-220.86M |
| Accounts Receivables | $- | $- | $-91.08M | $-83.08M | $-188.45M |
| Inventory | $- | $- | $- | $- | $- |
| Accounts Payables | $- | $-10.23M | $21.43M | $-3.00M | $754.00K |
| Other Working Capital | $7.62M | $71.05M | $-60.66M | $-14.68M | $-32.40M |
| Other Non Cash Items | $3.83M | $3.82M | $63.48M | $172.75M | $177.65M |
| Net Cash Provided by Operating Activities | $1.09B | $911.34M | $780.47M | $764.46M | $551.25M |
| Investments in Property Plant and Equipment | $- | $-26.20M | $-2.49M | $-2.49M | $567.00K |
| Acquisitions Net | $- | $- | $-7.78M | $-7.78M | $-448.16M |
| Purchases of Investments | $-2.58B | $-2.70B | $-2.00B | $-1.12B | $-979.29M |
| Sales Maturities of Investments | $1.90B | $1.65B | $1.00B | $792.92M | $654.34M |
| Other Investing Activities | $-20.52M | $- | $-3.24M | $-11.72M | $438.91M |
| Net Cash Used for Investing Activities | $-700.14M | $-1.08B | $-1.01B | $-346.15M | $-333.63M |
| Debt Repayment | $- | $- | $- | $-384.00K | $-1.04M |
| Common Stock Issued | $- | $62.69M | $43.65M | $51.54M | $34.86M |
| Common Stock Repurchased | $- | $-78.88M | $-63.03M | $-55.29M | $- |
| Dividends Paid | $- | $- | $- | $- | $- |
| Other Financing Activities | $26.11M | $-16.19M | $-19.38M | $-3.76M | $-1 |
| Net Cash Used Provided by Financing Activities | $26.11M | $-16.19M | $-19.38M | $-4.14M | $33.82M |
| Effect of Forex Changes on Cash | $-1.74M | $-1.78M | $-4.99M | $-4.66M | $484.00K |
| Net Change in Cash | $414.29M | $-182.98M | $-251.57M | $409.51M | $251.91M |
| Cash at End of Period | $1.12B | $706.67M | $889.65M | $1.14B | $731.71M |
| Cash at Beginning of Period | $706.67M | $889.65M | $1.14B | $731.71M | $479.80M |
| Operating Cash Flow | $1.09B | $911.34M | $780.47M | $764.46M | $551.25M |
| Capital Expenditure | $- | $-26.20M | $-2.49M | $-2.49M | $567.00K |
| Free Cash Flow | $1.09B | $885.14M | $777.98M | $761.97M | $551.81M |
Cash Flow Charts
| Breakdown | January 31, 2025 | October 31, 2024 | July 31, 2024 | April 30, 2024 | January 31, 2024 | October 31, 2023 | July 31, 2023 | April 30, 2023 | January 31, 2023 | October 31, 2022 | July 31, 2022 | April 30, 2022 | January 31, 2022 | October 31, 2021 | July 31, 2021 | April 30, 2021 | January 31, 2021 | October 31, 2020 | July 31, 2020 | April 30, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $- | $185.81M | $171.04M | $161.66M | $147.40M | $135.16M | $111.63M | $131.52M | $188.53M | $108.46M | $90.60M | $100.11M | $97.10M | $105.87M | $108.86M | $115.57M | $102.92M | $96.96M | $93.55M | $86.57M |
| Depreciation and Amortization | $-1.04M | $9.62M | $11.02M | $11.28M | $8.63M | $8.36M | $8.09M | $7.55M | $7.68M | $7.16M | $7.23M | $7.06M | $7.04M | $6.90M | $6.88M | $6.63M | $6.74M | $7.53M | $7.32M | $7.88M |
| Deferred Income Tax | $- | $-31.43M | $-33.26M | $-26.54M | $-25.24M | $-33.41M | $-25.21M | $-21.51M | $-43.13M | $-31.06M | $-20.88M | $-32.43M | $905.00K | $-2.02M | $6.95M | $5.24M | $2.48M | $-1.89M | $-504.00K | $-1.13M |
| Stock Based Compensation | $-1.70M | $-1.70M | $108.38M | $95.91M | $98.89M | $101.23M | $102.89M | $90.72M | $95.54M | $93.19M | $96.04M | $67.13M | $61.72M | $62.05M | $62.38M | $48.49M | $49.76M | $48.97M | $49.37M | $36.91M |
| Change in Working Capital | $- | $-117.97M | $-162.00M | $522.65M | $-171.83M | $95.02M | $77.42M | $292.22M | $-503.30M | $72.13M | $-9.47M | $288.89M | $-425.76M | $54.19M | $-28.60M | $302.41M | $-384.65M | $16.82M | $-2.35M | $149.32M |
| Accounts Receivables | $- | $102.68M | $- | $487.60M | $-596.73M | $116.13M | $34.06M | $334.06M | $-459.33M | $64.97M | $505.00K | $302.78M | $-414.79M | $55.28M | $-21.14M | $297.57M | $-374.25M | $20.86M | $15.22M | $149.71M |
| Inventory | $- | $- | $- | $- | $-21.79M | $- | $- | $- | $- | $- | $- | $- | $1.04M | $- | $- | $- | $27.56M | $- | $- | $- |
| Accounts Payables | $- | $- | $-3.62M | $280.00K | $-4.73M | $-13.56M | $6.10M | $1.96M | $766.00K | $10.00M | $5.54M | $5.12M | $-5.26M | $4.03M | $5.03M | $-6.79M | $1.21M | $3.06M | $914.00K | $-4.43M |
| Other Working Capital | $- | $-220.65M | $-158.38M | $30.92M | $406.77M | $-21.11M | $43.36M | $-41.85M | $-43.97M | $7.17M | $-9.97M | $-13.89M | $-10.97M | $-1.08M | $-7.46M | $4.83M | $-10.40M | $-4.04M | $-17.57M | $-391.00K |
| Other Non Cash Items | $72.29M | $119.78M | $-2.30M | $-370.86M | $8.14M | $-257.17M | $-35.00M | $-16.07M | $274.94M | $-138.27M | $-91.02M | $17.83M | $313.96M | $-116.05M | $-30.45M | $5.29M | $293.59M | $-74.87M | $-42.57M | $1.50M |
| Net Cash Provided by Operating Activities | $69.54M | $164.12M | $92.87M | $763.52M | $57.77M | $82.60M | $265.04M | $505.94M | $63.40M | $142.66M | $93.39M | $481.03M | $54.05M | $112.96M | $119.06M | $478.38M | $68.35M | $95.40M | $105.32M | $282.17M |
| Investments in Property Plant and Equipment | $- | $- | $-3.05M | $-8.48M | $-7.74M | $-5.91M | $-9.59M | $-2.96M | $-3.91M | $-17.00K | $-3.00K | $-2.33M | $-3.92M | $-223.00K | $104.00K | $806.00K | $-227.00K | $697.00K | $184.00K | $590.00K |
| Acquisitions Net | $- | $- | $- | $- | $7.74M | $5.91M | $9.59M | $2.96M | $3.91M | $- | $-2.13M | $2.33M | $-5.65M | $223.00K | $-2.13M | $-806.00K | $-446.69M | $-697.00K | $-184.00K | $-590.00K |
| Purchases of Investments | $- | $- | $-614.47M | $-777.83M | $-555.90M | $-541.50M | $-988.07M | $-612.49M | $-280.63M | $-710.83M | $-433.07M | $-572.34M | $-181.45M | $-256.01M | $-422.68M | $-256.94M | $-104.83M | $-417.90M | $-267.75M | $-188.82M |
| Sales Maturities of Investments | $- | $- | $503.68M | $513.93M | $476.93M | $474.09M | $378.74M | $318.06M | $245.27M | $310.71M | $250.53M | $196.19M | $135.86M | $248.09M | $187.32M | $221.65M | $126.15M | $158.63M | $229.22M | $140.34M |
| Other Investing Activities | $-15.69M | $-298.23M | $- | $-8.48M | $-7.74M | $-5.91M | $-9.59M | $-2.96M | $-3.91M | $-5.59M | $473.00K | $-2.33M | $-3.92M | $-2.31M | $-5.43M | $-2.66M | $-227.00K | $-3.32M | $-5.41M | $267.00K |
| Net Cash Used for Investing Activities | $-15.69M | $-298.23M | $-113.84M | $-272.38M | $-86.70M | $-73.32M | $-618.93M | $-297.39M | $-39.26M | $-405.73M | $-184.21M | $-378.49M | $-55.16M | $-10.23M | $-242.81M | $-37.95M | $21.09M | $-262.59M | $-43.93M | $-48.21M |
| Debt Repayment | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $-98.00K | $-286.00K | $-619.00K | $79.00K | $-251.00K | $-248.00K |
| Common Stock Issued | $- | $- | $6.40M | $28.43M | $10.50M | $13.96M | $23.00M | $15.23M | $13.54M | $4.58M | $9.25M | $16.29M | $8.23M | $5.37M | $20.85M | $17.09M | $-6.19M | $6.19M | $- | $- |
| Common Stock Repurchased | $- | $- | $-17.88M | $-24.61M | $-20.99M | $-20.84M | $-20.42M | $-16.62M | $-15.78M | $-15.12M | $-17.13M | $-15.00M | $-18.78M | $-21.41M | $-15.10M | $- | $- | $- | $- | $- |
| Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Other Financing Activities | $20.81M | $12.96M | $-11.48M | $3.83M | $-10.48M | $-6.89M | $2.58M | $-1.39M | $-2.24M | $-10.54M | $-7.88M | $1.29M | $-10.56M | $-16.05M | $5.75M | $17.09M | $9.61M | $6.19M | $9.28M | $9.78M |
| Net Cash Used Provided by Financing Activities | $20.81M | $12.96M | $-11.48M | $3.83M | $-10.48M | $-6.89M | $2.58M | $-1.39M | $-2.24M | $-10.54M | $-7.88M | $1.29M | $-10.56M | $-16.05M | $5.66M | $16.80M | $8.99M | $6.26M | $9.03M | $9.53M |
| Effect of Forex Changes on Cash | $-389.00K | $-94.00K | $5.00K | $-1.26M | $-807.00K | $-1.28M | $290.00K | $19.00K | $-489.00K | $-1.48M | $-1.05M | $-1.87M | $-243.00K | $-1.47M | $-180.00K | $-2.77M | $-2.20M | $-599.00K | $2.73M | $548.00K |
| Net Change in Cash | $74.27M | $-121.24M | $-32.45M | $493.71M | $-40.23M | $1.10M | $-351.03M | $207.17M | $21.31M | $-275.09M | $-99.75M | $101.96M | $-11.90M | $85.22M | $-118.27M | $454.48M | $96.24M | $-161.52M | $73.15M | $244.04M |
| Cash at End of Period | $1.12B | $1.05B | $1.17B | $1.20B | $703.49M | $746.89M | $745.79M | $1.10B | $889.65M | $868.34M | $1.14B | $1.24B | $1.14B | $1.15B | $1.07B | $1.19B | $731.71M | $635.47M | $796.99M | $723.84M |
| Cash at Beginning of Period | $1.05B | $1.17B | $1.20B | $703.49M | $743.71M | $745.79M | $1.10B | $889.65M | $868.34M | $1.14B | $1.24B | $1.14B | $1.15B | $1.07B | $1.19B | $731.71M | $635.47M | $796.99M | $723.84M | $479.80M |
| Operating Cash Flow | $69.54M | $164.12M | $92.87M | $763.52M | $57.77M | $82.60M | $265.04M | $505.94M | $63.40M | $142.66M | $93.39M | $481.03M | $54.05M | $112.96M | $119.06M | $478.38M | $68.35M | $95.40M | $105.32M | $282.17M |
| Capital Expenditure | $- | $- | $-3.05M | $-8.48M | $-7.74M | $-5.91M | $-9.59M | $-2.96M | $-3.91M | $-17.00K | $-3.00K | $-2.33M | $-3.92M | $-223.00K | $104.00K | $806.00K | $-227.00K | $697.00K | $184.00K | $590.00K |
| Free Cash Flow | $69.54M | $164.12M | $89.82M | $755.04M | $50.03M | $76.69M | $255.44M | $502.98M | $59.49M | $142.64M | $93.38M | $478.69M | $50.13M | $112.74M | $119.17M | $479.19M | $68.12M | $96.10M | $105.50M | $282.76M |
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
$228.33
Stock Price
$37.15B
Market Cap
7.29K
Employees
Pleasanton, CA
Location
Revenue (FY 2025)
$2.75B
16.2% YoY
Net Income (FY 2025)
$714.14M
35.8% YoY
EPS (FY 2025)
$4.32
34.2% YoY
Free Cash Flow (FY 2025)
$1.09B
23.1% YoY
Profitability
Gross Margin
74.5%
Net Margin
26.0%
ROE
12.2%
ROA
9.7%
Valuation
P/E Ratio
52.87
P/S Ratio
13.75
EV/EBITDA
53.10
Market Cap
$37.15B
Revenue & Net Income
Profit Margins
Cash Flow Summary
Operating Cash Flow
$1.09B
19.6% YoY
Free Cash Flow
$1.09B
23.1% YoY
Balance Sheet Summary
Total Assets
$7.34B
24.2% YoY
Total Debt
$75.78M
35.9% YoY
Shareholder Equity
$5.83B
24.5% YoY
Dividend Overview
No Dividend Data
Veeva Systems Inc. doesn't currently pay dividends.
Veeva Systems Dividends
Explore Veeva Systems's dividend history, including dividend yield, payout ratio, and historical payments.
Veeva Systems News
Read the latest news about Veeva Systems, including recent articles, headlines, and updates.
Announcing Veeva AI
Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial PLEASANTON, Calif. , April 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts.
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days.
Flatiron Health Joins Veeva's Product Partner Program to Accelerate Oncology Clinical Research
NEW YORK--(BUSINESS WIRE)--Flatiron Health, a healthtech company transforming clinical research through solutions that integrate research into everyday care, today announced they will partner with Veeva Systems, a global leader in cloud software for the life sciences industry. As part of the partnership, Flatiron Health will join the Veeva Product Partner Program. This collaboration builds on the integration of Flatiron Clinical Pipe™ and Veeva EDC (Electronic Data Capture), enhancing value and.
Why a Clutch of Pharmaceutical and Biotech Stocks Escaped the Market's Swoon on Thursday
As predicted by many analysts, economists, and investors, the sweeping tariffs announced by the Trump administration on Wednesday decimated the stock market on Thursday. It had one of its worst trading days in years, and almost no sector of the economy was spared.
Wall Street Analysts Think Veeva (VEEV) Is a Good Investment: Is It?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Veeva Announces Research Site Clinical Trial Management System
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsors PLEASANTON, Calif. , April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system.
Indero Marks 40th Study Live with Veeva RTSM
Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelines PLEASANTON, Calif. , March 19, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM.
Veeva Systems: Staying Buy Rated As VEEV Is Executing Well
I reaffirm my buy rating on Veeva Systems due to strong 4Q25 results, driven by R&D growth and positive Vault CRM adoption traction. VEEV's revenue grew 14% y/y to $721 million, beating expectations, with significant margin improvements and a strong balance sheet. Vault CRM added 20 new customers, with multiple top 20 pharma commitments expected in 2025, signaling positive transition progress.
Veeva (VEEV) Is Considered a Good Investment by Brokers: Is That True?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Boehringer Ingelheim Partners with Veeva to Launch 'One Medicine Platform'
Top 20 biopharma goes live with Veeva Development Cloud to speed the delivery of treatments for currently incurable diseases INGELHEIM, Germany and PLEASANTON, Calif. , March 11, 2025 /PRNewswire/ -- Today, Boehringer Ingelheim and Veeva Systems (NYSE: VEEV) have announced the launch of Boehringer's One Medicine Platform, powered by the successful implementation of Veeva Development Cloud.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for VEEV.